BioStem Technologies, Inc.
BSEM
$4.38
-$0.46-9.60%
OTC PK
| 06/30/2025 | 03/31/2025 | 09/30/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 3,443.55% | 3,443.55% | 3,565.17% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 3,443.55% | 3,443.55% | 3,565.17% |
| Cost of Revenue | -- | -- | 1,333.70% | 1,333.70% | 936.08% |
| Gross Profit | -- | -- | 3,752.00% | 3,752.00% | 4,170.02% |
| SG&A Expenses | -- | -- | 1,079.61% | 1,079.64% | 769.49% |
| Depreciation & Amortization | -- | -- | -6.33% | -6.33% | -9.03% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | 1,058.90% | 1,058.90% | 750.75% |
| Operating Income | -- | -- | 297.47% | 297.47% | 201.02% |
| Income Before Tax | -- | -- | 265.65% | 266.30% | 178.99% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -- | -- | 216.00% | 216.65% | 147.45% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | 216.48% | 217.13% | 148.06% |
| EBIT | -- | -- | 297.47% | 297.47% | 201.02% |
| EBITDA | -- | -- | 303.96% | 303.91% | 205.38% |
| EPS Basic | -- | -- | 192.29% | 192.82% | 134.41% |
| Normalized Basic EPS | -- | -- | 246.85% | 247.41% | 172.29% |
| EPS Diluted | -- | -- | 168.02% | 168.02% | 120.65% |
| Normalized Diluted EPS | -- | -- | 212.57% | 212.02% | 153.33% |
| Average Basic Shares Outstanding | -- | -- | 21.60% | 21.60% | 20.37% |
| Average Diluted Shares Outstanding | -- | -- | 45.17% | 45.99% | 35.36% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |